Background: Alice in Wonderland syndrome (AIWS) is a rare cluster of CNS symptoms characterized by visual distortions (i.e. metamorphopsias), body image distortions, time distortions, and déjà experiences. Verbal auditory hallucinations (VAHs) are the most prevalent type of hallucination in adults with or without a history of psychiatric illness. Here, we report the case of a woman with AIWS, long-lasting VAHs, and various additional perceptual and mood symptoms. Methods: Semi-structured interviews were used to assess symptoms, and functional MRI (fMRI) was employed to localize cerebral activity during self-reported VAHs. Treatment consisted of repetitive transcranial magnetic stimulation (rTMS) at a frequency of 1 Hz at T3P3, overlying Brodmann’s area 40. Results: Activation during VAHs was observed bilaterally in the basal ganglia, the primary auditory cortex, the association auditory cortex, the temporal poles, and the anterior cingulated gyrus. The left and right inferior frontal gyri (Broca’s area and its contralateral homologue) were involved, along with the dorsolateral prefrontal cortex. Interestingly, synchronized activation was observed in the primary visual cortex (areas V1 and V2), and the bilateral dorsal visual cortex. The higher visual association cortex also showed significant, but less prominent, activation. During the second week of rTMS treatment, not only the VAHs, but also the other sensory deceptions/distortions and mood symptoms showed complete remission. The patient remained free of any symptoms during a 4-month follow-up phase. After 8 months, when many of the original symptoms had returned, a second treatment phase with rTMS was again followed by complete remission. Conclusions: This case indicates that VAHs and metamorphopsias in AIWS are associated with synchronized activation in both auditory and visual cortices. It also indicates that local rTMS treatment may have global therapeutic effects, suggesting an effect on multiple brain regions in a distributed network. Although a placebo effect cannot be ruled out, this case warrants further investigation of the effects of rTMS treatment in AIWS.

Keywords:
Alice in Wonderland syndrome, Metamorphopsias, Auditory hallucinations, Functional magnetic resonance imaging, Repetitive transcranial magnetic stimulation
1.
Todd J: The syndrome of Alice in Wonderland. Can Med Assoc J 1955;73:701–704.
2.
Coleman SM: Misidentification and non-recognition. J Ment Sci 1933;79:42–51.
3.
Blom JD: A dictionary of hallucinations. New York, Springer, 2010.
4.
Kew J, Wright A, Halligan PW: Somesthetic aura: the experience of ‘Alice in Wonderland’. Lancet 1998;351:1934.
5.
Evans RW, Rolak LA: The Alice in Wonderland syndrome. Headache 2004;44:624–625.
6.
Lippman CW: Certain hallucinations peculiar to migraine. J Nerv Ment Dis 1952;116:346–351.
7.
Takaoka K, Takata T: ‘Alice in Wonderland’ syndrome and Lilliputian hallucinations in a patient with a substance-related disorder. Psychopathology 1999;32:47–49.
8.
Zwijnenburg PJ, Wennink JM, Laman DM, Linssen WH: Alice in Wonderland syndrome: a clinical presentation of frontal lobe epilepsy. Neuropediatrics 2002;33:53–55.
9.
Lane JC, Doran CM: Alice in wonderland syndrome meets bipolar disorder and OCD: the interface of neurology and psychiatry. Headache Pain Diagnostic Chall Curr Ther 2006;17:46–48.
10.
Liaw SB, Shen EY: Alice in Wonderland syndrome as a presenting symptom of EBV infection. Pediatr Neurol 1991;7:464–466.
11.
Hung KL, Liao HT, Tsai ML: Epstein-Barr virus encephalitis in children. Acta Paediatr Taiwan 2000;41:140–146.
12.
Kamei A, Sasaki M, Akasaka M, Chida S: Abnormal magnetic resonance imaging in a child with Alice in Wonderland syndrome following Epstein-Barr virus infection (article in Japanese). No To Hattatsu 2002;34:348–352.
13.
Lahat E, Berkovitch M, Barr J, Paret G, Barzilai A: Abnormal visual evoked potentials in children with ‘Alice in Wonderland’ syndrome due to infectious mononucleosis. J Child Neurol 1999;14:732–735.
14.
ffytche DH, Howard RJ: The perceptual consequences of visual loss: ‘positive’ pathologies of vision. Brain 1999;122:1247–1260.
15.
Hanssen M, Bak M, Bijl R, Vollebergh W, van Os J: The incidence and outcome of subclinical psychotic experiences in the general population. Br J Clin Psychol 2005;44:181–191.
16.
Ohayon MM: Prevalence of hallucinations and their pathological associations in the general population. Psychiatry Res 2000;97:153–164.
17.
Sommer IEC, Slotema CW, de Weijer AD, Blom JD, Neggers B, Hoek HW, Kahn RS: Can fMRI guidance improve the efficacy of rTMS treatment for auditory verbal hallucinations? Schizophr Res 2007;93:406–408.
18.
Sommer IEC, Diederen KMJ, Blom JD, Willems A, Kushan L, Slotema K, Boks MPM, Daalman K, Hoek HW, Neggers SFW, Kahn RS: Auditory verbal hallucinations predominantly activate the right inferior frontal area. Brain 2008;131:3169–3177.
19.
Kay S, Fiszbein A, Opler L: The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261–276.
20.
Haddock G, McCarron J, Tarrier N, Faragher EB: Scales to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales (PSYRATS). Psychol Med 1999;29:879–889.
21.
Neggers SF, Hermans EJ, Ramsey NF: Enhanced sensitivity with fast three-dimensional blood-oxygen-level-dependent functional MRI: comparison of SENSE-PRESTO and 2D-EPI at 3 T. NMR Biomed 2008;21:663–676.
22.
Jenkinson M, Bannister P, Brady M, Smith S: Improved optimisation for the robust and accurate linear registration and motion correction of brain images. Neuroimage 2002;17:825–841.
23.
Smith S: Fast robust automated brain extraction. Hum Brain Mapp 2002;17:143–155.
24.
Jenkinson M, Smith SM: A global optimisation method for robust affine registration of brain images. Med Image Anal 2001;5:143–156.
25.
Woolrich MW, Ripley BD, Brady JM, Smith SM: Temporal autocorrelation in univariate linear modeling of fMRI data. Neuroimage 2001;14:1370–1386.
26.
Worsley KJ: Statistical analysis of activation images; in Jezzard P, Matthews PM, Smith SM (eds): Functional MRI: An Introduction to Methods. Oxford, Oxford University Press, 2001.
27.
Dollfus S, Larmurier-Montagne A, Razafimandimby A, Delcroix N, Allio G, Membrey J, Etard O: Treatment of auditory hallucinations by combining high-frequency repetitive transcranial magnetic stimulation and functional magnetic resonance imaging. Schizophr Res 2008;102:348–351.
28.
Craig AD: Disembodied hallucinatory voices: comment on Sommer et al., 2008. Brain 2008;131:3169–3177.
29.
Hoffman RE, Hampson M, Wu K, Anderson AW, Gore JC, Buchanan RJ, Constable RT, Hawkins KA, Sahay N, Krystal JH: Probing the pathophysiology of auditory/verbal hallucinations by combining functional magnetic resonance imaging and transcranial magnetic stimulation. Cereb Cortex 2007;7:2733–2743.
30.
Sommer IEC, Ramsey NF, Kahn RS: Language lateralization in schizophrenia, an fMRI study. Schizophr Res 2001;52:57–67.
31.
Bloom JS, Hynd GW: The role of the corpus callosum in interhemispheric transfer of information: excitation or inhibition? Neuropsychol Rev 2005;15:59–71.
32.
Thiel A, Schumacher B, Wienhard K, Gairing S, Kracht LW, Wagner R, Haupt WF, Heiss WD: Direct demonstration of transcallosal disinhibition in language networks. J Cereb Blood Flow Metab 2006;26:1122–1127.
33.
Nasrallah HA: The unintegrated right cerebral hemispheric consciousness as alien intruder: a possible mechanism for schneiderian delusions in schizophrenia. Compr Psychiatry 1985;26:273–282.
34.
Sommer IE, Diederen KM: Language production in the non-dominant hemisphere as a potential source of auditory verbal hallucinations. Brain 2009;132:e124.
35.
Blom JD, Sommer IEC: Auditory hallucinations: nomenclature and classification. Cogn Behav Neurol 2010;23:55–62.
36.
Heo K, Cho YJ, Lee SK, Park SA, Kim KS, Lee BI: Single-photon emission computed tomography in a patient with ictal metamorphopsia. Seizure 2004;13:250–253.
37.
Hoksbergen I, Pickut BA, Mariën P, De Deyn PP, Slabbynck H, Kunnen J: SPECT findings in an unusual case of visual hallucinosis. J Neurol 1996;243:594–598.
38.
Gencoglu EA, Alehan F, Erol I, Koyuncu A, Aras M: Brain SPECT findings in a patient with Alice in Wonderland syndrome. Clin Nucl Med 2005;30:758–759.
39.
Kuo YT, Chiu NC, Shen EY, Ho CS, Wu MC: Cerebral perfusion in children with Alice in Wonderland syndrome. Pediatr Neurol 1998;19:105–108.
40.
Hubel DH, Wiesel TN: Receptive fields, binocular interaction and functional architecture in the cat’s visual cortex. J Physiol 1962;160:106–154.
41.
Hubel DH, Wiesel TN: Brain and Visual Perception. Oxford, Oxford University Press, 2005.
42.
Whitfield-Gabrieli S, Thermenos H, Milanovic S, Tsuang M, Faraone S, McCarley R, Shenton M, Green A, Nieto-Castanon A, Laviolette P, Wojcik J, Gabrieli J, Seidman L: Hyperactivity and hyperconnectivity of the default network in schizophrenia and in first-degree relatives of persons with schizophrenia. Proc Natl Acad Sci USA 2009;106:1279–1284.
43.
Daskalakis ZJ, Christensen BK, Chen R, Fitzgerald PB, Zipursky RB, Kapur S: Evidence for impaired cortical inhibition in schizophrenia using transcranial magnetic stimulation. Arch Gen Psychiatry 2002;59:347–354.
44.
Szycik GR, Münte TF, Dillo W, Mohammadi B, Samii A, Emrich HM, Dietrich DE: Audiovisual integration of speech is disturbed in schizophrenia: an fMRI study. Schizophr Res 2009;110:111–118.
45.
Slotema CW, Blom JD, de Weijer AD, Diederen KM, Goekoop R, Looijestijn J, Daalman K, Rijkaart AM, Kahn RS, Hoek HW, Sommer IEC: Can low-frequency rTMS really relieve medication-resistant auditory verbal hallucinations? Negative results from a large RCT. Biol Psychiatry 2011;69:450–456.
46.
Campbell RJ: Psychiatric Dictionary, ed 7. Oxford, Oxford University Press, 1996, p 315.
47.
Slotema CW, Blom JD, Hoek HW, Sommer IEC: Should we expand the toolbox of psychiatric treatment methods to include repetitive transcranial magnetic stimulation? A meta-analysis of the efficacy of rTMS for psychiatric disorders. J Clin Psychiatry 2010;71:873–884.
48.
Schutter DJLG: Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis. Psychol Med 2009;39:65–75.
49.
Ro T: Unconscious vision in action. Neuropsychologia 2008;46:379–383.
50.
Ro T: What can TMS tell us about visual awareness? Cortex 2010;46:110–113.
51.
Penfield W, Perot P: The brain’s record of auditory and visual experience: a final summary and discussion. Brain 1963;86:595–696.
52.
Gloor P, Olivier A, Quesney LF, Andermann F, Horowitz S: The role of the limbic system in experiential phenomena of temporal lobe epilepsy. Ann Neurol 1982;12:129–144.
53.
Minussi C, Ruzzoli M, Walsh V: The mechanism of transcranial magnetic stimulation in cognition. Cortex 2010;46:128–130.
54.
Bullmore E, Sporns O: Complex brain networks: graph theoretical analysis of structural and functional systems. Nat Rev Neurosci 2009;10:186–198.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.